Preparation and Crystallographic Analysis of a Complex of SARS-CoV-2 S-Protein Receptor-Binding Domain with a Virus-Neutralizing Nanoantibody

K. M. Boyko; Бойко К. М.; L. A. Varfolomeeva; Варфоломеева Л. А.; N. A. Egorkin; Егоркин Н. А.; M. E. Minyaev; Миняев М. Е.; I. A. Alekseeva; Алексеева И. А.; I. A. Favorskaya; Фаворская И. А.; E. I. Ryabova; Рябова Е. И.; V. V. Prokofiev; Прокофьев В. В.; I. B. Esmagambetov; Есмагамбетов И. Б.; D. V. Shcheblyakov; Щебляков Д. В.; D. Yu. Logunov; Логунов Д. Ю.; A. L. Gintsburg; Гинцбург А. Л.; V. O. Popov; Попов В. О.; N. N. Sluchanko; Случанко Н. Н.

doi:10.31857/S0023476123600830

Preparation and Crystallographic Analysis of a Complex of SARS-CoV-2 S-Protein Receptor-Binding Domain with a Virus-Neutralizing Nanoantibody

作者: Boyko K.¹, Varfolomeeva L.¹, Egorkin N.¹, Minyaev M.², Alekseeva I.³, Favorskaya I.³, Ryabova E.³, Prokofiev V.³, Esmagambetov I.³, Shcheblyakov D.³, Logunov D.³, Gintsburg A.⁴, Popov V.¹, Sluchanko N.¹^,3
隶属关系:
1. Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology,” Russian Academy of Sciences, 119071, Moscow, Russia
2. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia
3. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, 123098, Moscow, Russia
4. FSBI National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya of the Ministry of Health of Russia
期: 卷 68, 编号 6 (2023)
页面: 866-873
栏目: STRUCTURE OF MACROMOLECULAR COMPOUNDS
URL: https://journals.rcsi.science/0023-4761/article/view/231804
DOI: https://doi.org/10.31857/S0023476123600830
EDN: https://elibrary.ru/XOAIEU
ID: 231804

如何引用文章

全文:

开放存取

##reader.subscriptionAccessGranted##
受限制的访问

订阅存取

详细
作者简介
参考
补充文件
统计

详细

Coronavirus SARS-CoV-2 was the cause of global pandemic COVID-19 that has claimed millions of lives around the world. One of the approaches to the therapy of severe forms of COVID-19 is based on the use of virus-neutralizing antibodies against the receptor-binding domain (RBD) of the virus spike glycoprotein (S). Detailed structural data on particular epitopes recognized by these virus-neutralizing antibodies is an important aspect of the improvement of available antibodies in order to extend the range of recognized virus strains. A stoichiometric complex of the virus-neutralizing single-domain antibody P2C5 and the glycosylated form of SARS-CoV-2 S protein RBD was obtained. Despite numerous conditions in which the crystal growth of the complex was observed, these crystals showed poor diffraction, apparently because of heterogeneity associated with the glycosylation of RBD. With the aim of improving the crystal quality, deglycosylase PNGase F was produced in a bacterial expression system and deglycosylation of RBD was performed. Despite low solubility of the deglycosylated form of RBD, it retains the ability to bind to the nanoantibody P2C5, resulting in the formation of a stable heterodimeric complex during gel filtration. The crystals of this complex were obtained. They showed diffraction to a similar resolution of ~4 Å on a laboratory X-ray diffractometer and at a synchrotron radiation source. The symmetry space group, the unit cell parameters of the crystal, and its protein composition were determined.

作者简介

K. Boyko

Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology,” Russian Academy of Sciences, 119071, Moscow, Russia

Email: kmb@inbi.ras.ru
Россия, Москва

L. Varfolomeeva

Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology,” Russian Academy of Sciences, 119071, Moscow, Russia

Email: nikolai.sluchanko@mail.ru
Россия, Москва

N. Egorkin

Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology,” Russian Academy of Sciences, 119071, Moscow, Russia

Email: nikolai.sluchanko@mail.ru
Россия, Москва